Opioid Exposures Reported to U.S. Poison Centers

References

• Abdesselam, K., Dann, M. J., Alwis, R., Laroche, J., & Ileka-Priouzeau, S. (2018). At-a-glance - Opioid surveillance: Monitoring and responding to the evolving crisis. Health Promotion and Chronic Disease Prevention in Canada: research, Policy and Practice, 38(9), 312–316. https://doi.org/10.24095/hpcdp.38.9.02
   PubMed Web of Science ®Google Scholar
• Allen, J. D., Casavant, M. J., Spiller, H. A., Chounthirath, T., Hodges, N. L., & Smith, G. A. (2017). Prescription opioid exposures among children and adolescents in the United States: 2000–2015. Pediatrics, 139(4), e20163382. https://doi.org/10.1542/peds.2016-3382
   PubMed Web of Science ®Google Scholar
• American Association of Poison Control Centers (2012). National Poison Data System (NPDS) Data Dictionary. 24–41.
   Google Scholar
• American Association of Poison Control Centers (2014). National Poison Data System Coding Users’ Manual©. 67 - 72. https://aapcc.s3.amazonaws.com/pdfs/member-resources/NPDS_Coding_Users_Manual_v3.1_07May2014.pdf Accessed May 24, 2019.
   Google Scholar
• Barocas, J. A., Wang, J., Marshall, B. D. L., LaRochelle, M. R., Bettano, A., Bernson, D., Beckwith, C. G., Linas, B. P., & Walley, A. Y. (2019). Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug and Alcohol Dependence, 200, 59–63. https://doi.org/10.1016/j.drugalcdep.2019.03.014
   PubMed Web of Science ®Google Scholar
• Barthwell, A. G., Allgaier, J., & Egli, K. (2018). Definitive urine drug testing in office-based opioid treatment: A literature review. Critical Reviews in Toxicology, 48(10), 829–852. https://doi.org/10.1080/10408444.2018.1553935
   PubMed Web of Science ®Google Scholar
• Bartley, E. J., & Fillingim, R. B. (2013). Sex differences in pain: A brief review of clinical and experimental findings. British Journal of Anaesthesia, 111(1), 52–58. https://doi.org/10.1093/bja/aet127
   PubMed Web of Science ®Google Scholar
• Bawor, M., Dennis, B. B., Bhalerao, A., Plater, C., Worster, A., Varenbut, M., Daiter, J., Marsh, D. C., Desai, D., Steiner, M., Anglin, R., Pare, G., Thabane, L., & Samaan, Z. (2015). Sex differences in outcomes of methadone maintenance treatment for opioid use disorder: A systematic review and meta-analysis. CMAJ Open, 3(3), E344–351. https://doi.org/10.9778/cmajo.20140089
   PubMedGoogle Scholar
• Bedene, A., Lijfering, W. M., Niesters, M., van Velzen, M., Rosendaal, F. R., Bouvy, M. L., Dahan, A., & van Dorp, E. L. A. (2019). Opioid Prescription Patterns and Risk Factors Associated With Opioid Use in the Netherlands. JAMA Network Open, 2(8), e1910223. https://doi.org/10.1001/jamanetworkopen.2019.10223
   PubMed Web of Science ®Google Scholar
• Bernhardt, M. B., Taylor, R. S., Hagan, J. L., Patel, N., Chumpitazi, C. E., Fox, K. A., & Glover, C. (2017). Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products. Journal of the American Society of Health-System Pharmacists, 74(24), 2046–2053. https://doi.org/10.2146/ajhp160548
   PubMed Web of Science ®Google Scholar
• Bohnert, A. S. B., Guy, G. P., Jr., & Losby, J. L. (2018). Opioid prescribing in the United States before and after the centers for disease control and prevention’s 2016 opioid guideline. Annals of Internal Medicine, 169(6), 367–375. https://doi.org/10.7326/M18-1243
   PubMed Web of Science ®Google Scholar
• Bohnert, A. S. B., & Ilgen, M. A. (2019). Understanding links among opioid use, overdose, and suicide. The New England Journal of Medicine, 380(1), 71–79. https://doi.org/10.1056/NEJMra1802148
   PubMed Web of Science ®Google Scholar
• Braden, J. B., Edlund, M. J., & Sullivan, M. D. (2017). Suicide deaths with opioid poisoning in the United States: 1999-2014. American Journal of Public Health, 107(3), 421–426. https://doi.org/10.2105/AJPH.2016.303591
   PubMed Web of Science ®Google Scholar
• Brady, J. E., Giglio, R., Keyes, K. M., DiMaggio, C., & Li, G. (2017). Risk markers for fatal and non-fatal prescription drug overdose: A meta-analysis. Injury Epidemiology, 4(1), 24. https://doi.org/10.1186/s40621-017-0118-7
   PubMedGoogle Scholar
• Calcaterra, S. L., Severtson, S. G., Bau, G. E., Margolin, Z. R., Bucher-Bartelson, B., Green, J. L., & Dart, R. C. (2018). Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014. Clinical Toxicology, 56(11), 1107–1114. https://doi.org/10.1080/15563650.2018.1457792
   Web of Science ®Google Scholar
• Carter, M. W., Yang, B. K., Davenport, M., & Kabel, A. (2019). Increasing rates of opioid misuse among older adults visiting emergency departments. Innovation in Aging, 3(1), 1–13. https://doi.org/10.1093/geroni/igz002
   Google Scholar
• Castillo, T. (2018). Harm reduction strategies for the opiod crisis. North Carolina Medical Journal, 79(3), 192–194. https://doi.org/10.18043/ncm.79.3.192
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC) (2005). CDC fact sheet: Using the national poisoning data system for public health surveillance — a collaborative effort of the centers for disease control and prevention and the american association of poison control centers. Retrieved from https://www.cdc.gov/nceh/hsb/chemicals/pdfs/npds.pdf. Accessed on April 22, 2019.
   Google Scholar
• Centers for Disease Control and Prevention (CDC) (2019). Prescription opioid overdose data. Retrieved from https://www.cdc.gov/drugoverdose/data/. Accessed on May 24, 2019.
   Google Scholar
• Coplan, P. M., Kale, H., Sandstrom, L., Landau, C., & Chilcoat, H. D. (2013). Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics. Pharmacoepidemiology and Drug Safety, 22(12), 1274–1282. https://doi.org/10.1002/pds.3522
   PubMed Web of Science ®Google Scholar
• Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L. (2015). Trends in opioid analgesic abuse and mortality in the United States. The New England Journal of Medicine, 372(3), 241–248. https://doi.org/10.1056/NEJMsa1406143
   PubMed Web of Science ®Google Scholar
• Dasgupta, N., B. J., Dart, R. I. (2017). Implications of declining poison center case volume on drug abuse trend monitoring. RADARS System Technical Report, 2017-Q3. https://www.radars.org/system/publications/2017%203Q%20QTR.pdf. Accessed on April 14, 2019.
   Google Scholar
• Davis, M. A., Lin, L. A., Liu, H., & Sites, B. D. (2017). Prescription opioid use among adults with mental health disorders in the United States. The Journal of the American Board of Family. 30(4), 407–417. https://doi.org/10.3122/jabfm.2017.04.170112
   PubMed Web of Science ®Google Scholar
• Dowell, D., Noonan, R. K., & Houry, D. (2017). Underlying factors in drug overdose deaths. JAMA, 318(23), 2295–2296. https://doi.org/10.1001/jama.2017.15971
   PubMed Web of Science ®Google Scholar
• Doyon, S., Aks, S. E., & Schaeffer, S. (2014). Expanding access to naloxone in the United States. Journal of Medical Toxicology: official Journal of the American College of Medical Toxicology, 10(4), 431–434. https://doi.org/10.1007/s13181-014-0432-1
   PubMedGoogle Scholar
• Evans, E., Kelleghan, A., Li, L., Min, J., Huang, D., Urada, D., Hser, Y. I., & Nosyk, B. (2015). Gender differences in mortality among treated opioid dependent patients. Drug and Alcohol Dependence, 155, 228–235. https://doi.org/10.1016/j.drugalcdep.2015.07.010
   PubMed Web of Science ®Google Scholar
• Garcia, M. C., Heilig, C. M., Lee, S. H., Faul, M., Guy, G., Iademarco, M. F., Hempstead, K., Raymond, D., & Gray, J. (2019). Opioid prescribing rates in nonmetropolitan and metropolitan counties among primary care providers using an electronic health record system - United States, 2014-2017. MMWR. Morbidity and Mortality Weekly Report, 68(2), 25–30. https://doi.org/10.15585/mmwr.mm6802a1
   PubMed Web of Science ®Google Scholar
• Giraudon, I. M. F., Hedrich, D., Vicente, J., Noor, A. (2019). Drug-related deaths and mortality in Europe (http://www.emcdda.europa.eu/system/files/publications/11485/20193286_TD0319444ENN_PDF.pdf Accessed May 24, 2019.
   Google Scholar
• Gomes, T., Tadrous, M., Mamdani, M. M., Paterson, J. M., & Juurlink, D. N. (2018). The burden of opioid-related mortality in the United States. JAMA Network Open, 1(2), e180217. https://doi.org/10.1001/jamanetworkopen.2018.0217
   PubMed Web of Science ®Google Scholar
• Green, J. L., Bucher Bartelson, B., Le Lait, M. C., Roland, C. L., Masters, E. T., Mardekian, J., Bailey, J. E., & Dart, R. C. (2017). Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration. Drug Alcohol Depend, 175, 140–145. https://doi.org/10.1016/j.drugalcdep.2017.01.039
   PubMed Web of Science ®Google Scholar
• Guy, G. P., Jr., Zhang, K., Bohm, M. K., Losby, J., Lewis, B., Young, R., Murphy, L. B., & Dowell, D. (2017). Vital signs: Changes in opioid prescribing in the United States, 2006-2015. MMWR. Morbidity and Mortality Weekly Report, 66(26), 697–704. https://doi.org/10.15585/mmwr.mm6626a4
   PubMed Web of Science ®Google Scholar
• Han, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones, C. M. (2017). Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National survey on drug use and health. Annals of Internal Medicine, 167(5), 293–301. https://doi.org/10.7326/M17-0865
   PubMed Web of Science ®Google Scholar
• Hauser, W., Petzke, F., Radbruch, L., & Tolle, T. R. (2016). The opioid epidemic and the long-term opioid therapy for chronic noncancer pain revisited: A transatlantic perspective. Pain Management, 6(3), 249–263. https://doi.org/10.2217/pmt.16.5
   PubMed Web of Science ®Google Scholar
• Hawkins, E. J., Goldberg, S. B., Malte, C. A., & Saxon, A. J. (2019). New coprescription of opioids and benzodiazepines and mortality among veterans affairs patients with posttraumatic stress disorder. The Journal of Clinical Psychiatry, 80(4). https://doi.org/10.4088/JCP.18m12689
   PubMed Web of Science ®Google Scholar
• Hedegaard, H., Bastian, B. A., Trinidad, J. P., Spencer, M., & Warner, M. (2018). Drugs most frequently involved in drug overdose deaths: United States, 2011-2016. National Vital Statistics Reports : From the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, 67(9), 1–14. https://www.ncbi.nlm.nih.gov/pubmed/30707673
   PubMedGoogle Scholar
• Hedegaard, H., Warner, M., & Minino, A. M. (2017). Drug overdose deaths in the United States, 1999-2016. NCHS Data Brief, (294), 1–8. https://www.ncbi.nlm.nih.gov/pubmed/29319475
   Google Scholar
• Hernandez, I., He, M., Brooks, M. M., & Zhang, Y. (2018). Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in medicare part d beneficiaries. JAMA Network Open, 1(2), e180919https://doi.org/10.1001/jamanetworkopen.2018.0919
   PubMed Web of Science ®Google Scholar
• Hirschtritt, M. E., Delucchi, K. L., & Olfson, M. (2018). Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993-2014. Preventive Medicine Reports, 9, 49–54. https://doi.org/10.1016/j.pmedr.2017.12.010
   PubMedGoogle Scholar
• Iwanicki, J. L., Severtson, S. G., Margolin, Z., Dasgupta, N., Green, J. L., & Dart, R. C. (2018). Consistency between opioid-related mortality trends derived from poison center and national vital statistics system, United States, 2006-2016. American Journal of Public Health, 108(12), 1639–1645. https://doi.org/10.2105/AJPH.2018.304728
   PubMed Web of Science ®Google Scholar
• Jiang, R., Lee, I., Lee, T. A., & Pickard, A. S. (2017). The societal cost of heroin use disorder in the United States. PLoS One, 12(5), e0177323. https://doi.org/10.1371/journal.pone.0177323
   PubMed Web of Science ®Google Scholar
• Jones, C. M. (2012). Frequency of prescription pain reliever nonmedical use: 2002-2003 and 2009-2010. Archievs of Internal Medicine, 172(16), 1265–1267. https://doi.org/10.1001/archinternmed.2012.2533
   PubMedGoogle Scholar
• Kennedy, M. C., Karamouzian, M., & Kerr, T. (2017). Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Current HIV/AIDS Reports, 14(5), 161–183. https://doi.org/10.1007/s11904-017-0363-y
   PubMed Web of Science ®Google Scholar
• Kerensky, T., & Walley, A. Y. (2017). Opioid overdose prevention and naloxone rescue kits: What we know and what we don’t know. Addiction Science & Clinical Practice, 12(1), 4. https://doi.org/10.1186/s13722-016-0068-3
   PubMedGoogle Scholar
• Khan, F., Krishnan, A., Ghani, M. A., Wickersham, J. A., Fu, J. J., Lim, S. H., Dhaliwal, S. K., Kamarulzaman, A., & Altice, F. L. (2018). Assessment of an innovative voluntary substance abuse treatment program designed to replace compulsory drug detention centers in Malaysia. Substance Use & Misuse, 53(2), 249–259. https://doi.org/10.1080/10826084.2016.1267217
   PubMed Web of Science ®Google Scholar
• Land, M. E., Wetzel, M., Geller, R. J., Kamat, P. P., & Grunwell, J. R. (2019). Analysis of 207,543 children with acute opioid poisonings from the United States National Poison Data System. Clinical Toxicology (Phila), 12, 1–8. https://doi.org/10.1080/15563650.2019.1691731
   Google Scholar
• Land, M. E., Wetzel, M., Geller, R. J., Steck, A. R., & Grunwell, J. R. (2021). Adult opioid poisonings by drug, intent, and resource use from the United States National Poison Data System from 2005-2018. Clinical Toxicology (Philadelphia, Pa.), 59(2), 142–151. https://doi.org/10.1080/15563650.2020.1781150
   PubMed Web of Science ®Google Scholar
• Larance, B., Dobbins, T., Peacock, A., Ali, R., Bruno, R., Lintzeris, N., Farrell, M., & Degenhardt, L. (2018). The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: Main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study. The Lancet. Psychiatry, 5(2), 155–166. https://doi.org/10.1016/S2215-0366(18)30003-8
   PubMed Web of Science ®Google Scholar
• Mallama, C. A., Trinidad, J. P., Swain, R. S., Zhao, Y., Woods, C., & McAninch, J. K. (2019). A comparison of opioid-involved fatalities captured in the National Poison Data System to data derived from US death certificate literal text. Pharmacoepidemiology and Drug Safety, 28(10), 1377–1385. https://doi.org/10.1002/pds.4869
   PubMed Web of Science ®Google Scholar
• Mazure, C. M., & Fiellin, D. A. (2018). Women and opioids: Something different is happening here. Lancet (London, England), 392(10141), 9–11. https://doi.org/10.1016/S0140-6736(18)31203-0
   PubMed Web of Science ®Google Scholar
• Morley, K. I., Ferris, J. A., Winstock, A. R., & Lynskey, M. T. (2017). Polysubstance use and misuse or abuse of prescription opioid analgesics: A multi-level analysis of international data. Pain, 158(6), 1138–1144. https://doi.org/10.1097/j.pain.0000000000000892
   PubMed Web of Science ®Google Scholar
• Mowry, J. B., Spyker, D. A., Brooks, D. E., Zimmerman, A., & Schauben, J. L. (2016). 2015 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 33rd Annual Report. Clinical Toxicology (Philadelphia, Pa.), 54(10), 924–1109. https://doi.org/10.1080/15563650.2016.1245421
   PubMed Web of Science ®Google Scholar
• Mueller, S. R., Walley, A. Y., Calcaterra, S. L., Glanz, J. M., & Binswanger, I. A. (2015). A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Substance Abuse, 36(2), 240–253. https://doi.org/10.1080/08897077.2015.1010032
   PubMed Web of Science ®Google Scholar
• Murphy, D. L., Lebin, J. A., Severtson, S. G., Olsen, H. A., Dasgupta, N., & Dart, R. C. (2018). Comparative rates of mortality and serious adverse effects among commonly prescribed opioid analgesics. Drug Safety, 41(8), 787–795. https://doi.org/10.1007/s40264-018-0660-4
   PubMed Web of Science ®Google Scholar
• Naun, C. A., Olsen, C. S., Dean, J. M., Olson, L. M., Cook, L. J., & Keenan, H. T. (2011). Can poison control data be used for pharmaceutical poisoning surveillance?Journal of the American Medical Informatics Association : JAMIA, 18(3), 225–231. https://doi.org/10.1136/jamia.2010.004317
   PubMed Web of Science ®Google Scholar
• Nielsen, S., & Van Hout, M. C. (2016). What is known about community pharmacy supply of naloxone? A scoping review. The International Journal on Drug Policy, 32, 24–33. https://doi.org/10.1016/j.drugpo.2016.02.006
   PubMed Web of Science ®Google Scholar
• Nosyk, B., Li, L., Evans, E., Urada, D., Huang, D., Wood, E., Rawson, R., & Hser, Y. I. (2014). Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012. Drug and Alcohol Dependence, 143, 149–157. https://doi.org/10.1016/j.drugalcdep.2014.07.020
   PubMed Web of Science ®Google Scholar
• Patel, A. M., Wheeler, D. C., Rose, S. R., Nadpara, P. A., Pakyz, A. L., & Carroll, N. V. (2019). Prevalence and characteristics of pediatric opioid exposures and poisonings in the United States. The Journal of Pediatrics, 206, 148–155. https://doi.org/10.1016/j.jpeds.2018.10.047
   Google Scholar
• Patrick, S. W., Fry, C. E., Jones, T. F., & Buntin, M. B. (2016). Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Affairs (Project Hope), 35(7), 1324–1332. https://doi.org/10.1377/hlthaff.2015.1496
   PubMed Web of Science ®Google Scholar
• Quilliam, B. J., Simeone, J. C., & Ozbay, A. B. (2011). Risk factors for hypoglycemia-related hospitalization in patients with type 2 diabetes: A nested case-control study. Clinical Therapeutics, 33(11), 1781–1791. https://doi.org/10.1016/j.clinthera.2011.09.020
   PubMed Web of Science ®Google Scholar
• Raji, M. A., Kuo, Y. F., Adhikari, D., Baillargeon, J., & Goodwin, J. S. (2018). Decline in opioid prescribing after federal rescheduling of hydrocodone products. Pharmacoepidemiology and Drug Safety, 27(5), 513–519. https://doi.org/10.1002/pds.4376
   PubMed Web of Science ®Google Scholar
• Rege, S. V., Ngo, D. A., Ait-Daoud, N., & Holstege, C. P. (2019). Epidemiology of severe buprenorphine exposures reported to the U.S. Poison Centers. Drug Alcohol Depend, 202, 115–122. https://doi.org/10.1016/j.drugalcdep.2019.05.015
   PubMed Web of Science ®Google Scholar
• Rege, S. V., Ngo, D. A., Ait-Daoud, N., Sharma, S., Verplancken, E., & Holstege, C. P. (2018). Trends and characteristics of naloxone therapy reported to US poison centers. Addiction, 113(12), 2309–2315. https://doi.org/10.1111/add.14378
   PubMed Web of Science ®Google Scholar
• Reifler, L. M., Droz, D., Bailey, J. E., Schnoll, S. H., Fant, R., Dart, R. C., & Bucher Bartelson, B. (2012). Do prescription monitoring programs impact state trends in opioid abuse/misuse?Pain Medicine (Malden, Mass.), 13(3), 434–442. https://doi.org/10.1111/j.1526-4637.2012.01327.x
   PubMed Web of Science ®Google Scholar
• Reinhart, M., Scarpati, L. M., Kirson, N. Y., Patton, C., Shak, N., & Erensen, J. G. (2018). The economic burden of abuse of prescription opioids: A systematic literature review from 2012 to 2017. Applied Health Economics and Health Policy, 16(5), 609–632. https://doi.org/10.1007/s40258-018-0402-x
   PubMed Web of Science ®Google Scholar
• Rose, A. J., McBain, R., Schuler, M. S., LaRochelle, M. R., Ganz, D. A., Kilambi, V., Stein, B. D., Bernson, D., Chui, K. K. H., Land, T., Walley, A. Y., & Stopka, T. J. (2019). Effect of age on opioid prescribing, overdose, and mortality in Massachusetts, 2011 to 2015. Journal of the American Geriatrics Society, 67(1), 128–132. https://doi.org/10.1111/jgs.15659
   PubMed Web of Science ®Google Scholar
• Roxburgh, A., Hall, W. D., Dobbins, T., Gisev, N., Burns, L., Pearson, S., & Degenhardt, L. (2017). Trends in heroin and pharmaceutical opioid overdose deaths in Australia. Drug and Alcohol Dependence, 179, 291–298. https://doi.org/10.1016/j.drugalcdep.2017.07.018
   PubMed Web of Science ®Google Scholar
• Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2018). Drug and opioid-involved overdose deaths - United States, 2013-2017. MMWR. Morbidity and Mortality Weekly Report, 67(5152), 1419–1427. https://doi.org/10.15585/mmwr.mm675152e1
   PubMedGoogle Scholar
• Serdarevic, M., Striley, C. W., & Cottler, L. B. (2017). Sex differences in prescription opioid use. Current Opinion in Psychiatry, 30(4), 238–246. https://doi.org/10.1097/YCO.0000000000000337
   PubMed Web of Science ®Google Scholar
• Sessler, N. E., Downing, J. M., Kale, H., Chilcoat, H. D., Baumgartner, T. F., & Coplan, P. M. (2014). Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation. Pharmacoepidemiology and Drug Safety, 23(12), 1238–1246. https://doi.org/10.1002/pds.3658
   PubMed Web of Science ®Google Scholar
• Severtson, S. G., Bartelson, B. B., Davis, J. M., Munoz, A., Schneider, M. F., Chilcoat, H., Coplan, P. M., Surratt, H., & Dart, R. C. (2013). Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. The Journal of Pain, 14(10), 1122–1130. https://doi.org/10.1016/j.jpain.2013.04.011
   PubMed Web of Science ®Google Scholar
• Stevens, J. P., Wall, M. J., Novack, L., Marshall, J., Hsu, D. J., & Howell, M. D. (2017). The critical care crisis of opioid overdoses in the United States. Annals of the American Thoracic Society, 14(12), 1803–1809. https://doi.org/10.1513/AnnalsATS.201701-022OC
   PubMed Web of Science ®Google Scholar
• Vivolo-Kantor, A. M., Seth, P., Gladden, R. M., Mattson, C. L., Baldwin, G. T., Kite-Powell, A., & Coletta, M. A. (2018). Vital signs: Trends in emergency department visits for suspected opioid overdoses - United States, July 2016-September 2017. MMWR. Morbidity and Mortality Weekly Report, 67(9), 279–285. https://doi.org/10.15585/mmwr.mm6709e1
   PubMed Web of Science ®Google Scholar
• West, N. A., Severtson, S. G., Green, J. L., & Dart, R. C. (2015). Trends in abuse and misuse of prescription opioids among older adults. Drug Alcohol Depend, 149, 117–121. https://doi.org/10.1016/j.drugalcdep.2015.01.027
   PubMed Web of Science ®Google Scholar
• Wheeler, E., Jones, T. S., Gilbert, M. K., & Davidson, P. J, Centers for Disease Control & Prevention. (2015). Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014. MMWR. Morbidity and Mortality Weekly Report, 64(23), 631–635. https://www.ncbi.nlm.nih.gov/pubmed/26086633
   PubMed Web of Science ®Google Scholar
• Winkelman, T. N. A., Chang, V. W., & Binswanger, I. A. (2018). Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Network Open, 1(3), e180558. https://doi.org/10.1001/jamanetworkopen.2018.0558
   PubMed Web of Science ®Google Scholar
• Wolkin, A. F., Martin, C. A., Law, R. K., Schier, J. G., & Bronstein, A. C. (2012). Using poison center data for national public health surveillance for chemical and poison exposure and associated illness. Annals of emergency medicine, 59(1), 56–61. https://doi.org/10.1016/j.annemergmed.2011.08.004
   PubMed Web of Science ®Google Scholar
• Wood, E. (2018). Strategies for reducing opioid-overdose deaths - lessons from Canada. The New England Journal of Medicine, 378(17), 1565–1567. https://doi.org/10.1056/NEJMp1800216
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) (2018). Management of substance abuse. Retrieved from: https://www.who.int/substance_abuse/facts/psychoactives/en/. Accessed on June 21, 2019.
   Google Scholar